Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Shock, Cardiogenic | 15 | 2024 | 688 | 3.030 |
Why?
|
Coronary Care Units | 10 | 2023 | 214 | 2.150 |
Why?
|
Heart Failure | 23 | 2024 | 10895 | 2.060 |
Why?
|
Glucosides | 5 | 2024 | 451 | 1.950 |
Why?
|
Benzhydryl Compounds | 6 | 2024 | 845 | 1.590 |
Why?
|
Cardiology | 9 | 2024 | 1668 | 1.380 |
Why?
|
Myocardial Infarction | 11 | 2023 | 11718 | 1.270 |
Why?
|
Cardiopulmonary Resuscitation | 5 | 2022 | 980 | 1.200 |
Why?
|
Hemorrhage | 6 | 2022 | 3461 | 1.160 |
Why?
|
Biphenyl Compounds | 2 | 2021 | 913 | 1.100 |
Why?
|
Heart-Assist Devices | 5 | 2023 | 1195 | 1.100 |
Why?
|
Foramen Ovale, Patent | 2 | 2019 | 223 | 1.090 |
Why?
|
Tricuspid Valve | 2 | 2019 | 403 | 1.090 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2019 | 349 | 1.030 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2021 | 923 | 0.990 |
Why?
|
Acute Coronary Syndrome | 6 | 2023 | 2337 | 0.990 |
Why?
|
Intra-Aortic Balloon Pumping | 4 | 2024 | 219 | 0.910 |
Why?
|
Thiazoles | 2 | 2021 | 1483 | 0.870 |
Why?
|
Pyridines | 3 | 2021 | 2825 | 0.870 |
Why?
|
Hemodynamics | 3 | 2023 | 4196 | 0.850 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2023 | 2073 | 0.840 |
Why?
|
Atrial Fibrillation | 7 | 2023 | 5035 | 0.830 |
Why?
|
Embolism | 3 | 2021 | 408 | 0.830 |
Why?
|
Heart Massage | 2 | 2019 | 30 | 0.780 |
Why?
|
Dyspnea | 2 | 2019 | 1303 | 0.770 |
Why?
|
Stroke Volume | 5 | 2023 | 5006 | 0.760 |
Why?
|
Calgranulin A | 1 | 2021 | 79 | 0.760 |
Why?
|
Calgranulin B | 1 | 2021 | 84 | 0.750 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2022 | 339 | 0.730 |
Why?
|
Critical Care | 12 | 2024 | 2647 | 0.730 |
Why?
|
Thromboembolism | 3 | 2021 | 987 | 0.720 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 1520 | 0.710 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 11726 | 0.690 |
Why?
|
Intensive Care Units | 11 | 2024 | 3680 | 0.680 |
Why?
|
Natriuretic Peptide, Brain | 6 | 2024 | 1572 | 0.670 |
Why?
|
Hospitals, Special | 1 | 2019 | 101 | 0.660 |
Why?
|
P-Selectin | 1 | 2021 | 601 | 0.650 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2019 | 95 | 0.630 |
Why?
|
Coronary Restenosis | 1 | 2021 | 424 | 0.630 |
Why?
|
Personnel, Hospital | 1 | 2020 | 283 | 0.620 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15160 | 0.580 |
Why?
|
Troponin I | 1 | 2021 | 619 | 0.570 |
Why?
|
Hospitalization | 9 | 2024 | 10259 | 0.570 |
Why?
|
Secondary Prevention | 2 | 2021 | 1530 | 0.570 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2017 | 97 | 0.550 |
Why?
|
Risk Assessment | 13 | 2023 | 23336 | 0.540 |
Why?
|
Cardiovascular System | 1 | 2023 | 831 | 0.530 |
Why?
|
Guidelines as Topic | 2 | 2019 | 1405 | 0.500 |
Why?
|
Hospital Mortality | 14 | 2023 | 5316 | 0.490 |
Why?
|
Burnout, Professional | 2 | 2020 | 694 | 0.480 |
Why?
|
Patient Care | 1 | 2019 | 640 | 0.460 |
Why?
|
Atherosclerosis | 4 | 2023 | 3444 | 0.460 |
Why?
|
Registries | 13 | 2024 | 8091 | 0.460 |
Why?
|
Workload | 1 | 2019 | 849 | 0.460 |
Why?
|
Lactones | 1 | 2016 | 329 | 0.450 |
Why?
|
Stroke | 5 | 2023 | 9981 | 0.430 |
Why?
|
Ventricular Function, Left | 3 | 2021 | 3666 | 0.420 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2020 | 1354 | 0.410 |
Why?
|
Occupational Diseases | 1 | 2020 | 1469 | 0.400 |
Why?
|
Thoracic Surgical Procedures | 1 | 2015 | 342 | 0.390 |
Why?
|
North America | 5 | 2023 | 1249 | 0.390 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1607 | 0.380 |
Why?
|
Thrombosis | 2 | 2022 | 2968 | 0.370 |
Why?
|
Humans | 75 | 2024 | 744366 | 0.370 |
Why?
|
Myocarditis | 1 | 2017 | 771 | 0.350 |
Why?
|
Troponin | 3 | 2023 | 524 | 0.340 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1956 | 0.340 |
Why?
|
Education, Medical, Graduate | 2 | 2019 | 2291 | 0.330 |
Why?
|
Pneumonia, Pneumocystis | 2 | 2020 | 249 | 0.330 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1440 | 0.320 |
Why?
|
Heart Arrest | 4 | 2020 | 1470 | 0.320 |
Why?
|
Anticoagulants | 3 | 2022 | 4600 | 0.320 |
Why?
|
Proteomics | 1 | 2021 | 3638 | 0.310 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3154 | 0.300 |
Why?
|
Catheters, Indwelling | 2 | 2019 | 426 | 0.280 |
Why?
|
Internship and Residency | 4 | 2020 | 5791 | 0.260 |
Why?
|
Drug Combinations | 2 | 2021 | 1958 | 0.260 |
Why?
|
Critical Illness | 4 | 2022 | 2670 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.260 |
Why?
|
Risk Factors | 15 | 2024 | 72296 | 0.260 |
Why?
|
Emergency Medical Services | 2 | 2019 | 1917 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.250 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 3070 | 0.250 |
Why?
|
Myocardium | 1 | 2017 | 4772 | 0.240 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2021 | 1516 | 0.230 |
Why?
|
Middle Aged | 21 | 2022 | 213390 | 0.230 |
Why?
|
Aged | 19 | 2024 | 163288 | 0.230 |
Why?
|
Patient Admission | 3 | 2019 | 1380 | 0.230 |
Why?
|
Risk | 3 | 2021 | 9688 | 0.230 |
Why?
|
Lactates | 1 | 2023 | 432 | 0.220 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2022 | 31 | 0.220 |
Why?
|
Female | 30 | 2022 | 380193 | 0.210 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2022 | 45 | 0.210 |
Why?
|
Arrhythmias, Cardiac | 3 | 2023 | 2269 | 0.200 |
Why?
|
Electric Countershock | 2 | 2019 | 534 | 0.200 |
Why?
|
Lymphopenia | 2 | 2020 | 285 | 0.200 |
Why?
|
Male | 27 | 2022 | 350115 | 0.200 |
Why?
|
Hospital Rapid Response Team | 1 | 2021 | 57 | 0.190 |
Why?
|
Respiration, Artificial | 1 | 2012 | 2569 | 0.190 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.190 |
Why?
|
Vascular Resistance | 1 | 2023 | 936 | 0.190 |
Why?
|
Time Factors | 9 | 2021 | 40075 | 0.190 |
Why?
|
Chest Wall Oscillation | 1 | 2020 | 12 | 0.190 |
Why?
|
Patients' Rooms | 1 | 2020 | 63 | 0.180 |
Why?
|
Protective Devices | 1 | 2020 | 71 | 0.180 |
Why?
|
Treatment Outcome | 13 | 2024 | 63107 | 0.180 |
Why?
|
Platelet Function Tests | 1 | 2021 | 270 | 0.170 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10183 | 0.170 |
Why?
|
CD40 Ligand | 1 | 2021 | 526 | 0.170 |
Why?
|
Peptide Fragments | 5 | 2024 | 5096 | 0.170 |
Why?
|
Telecommunications | 1 | 2019 | 80 | 0.170 |
Why?
|
Enalapril | 1 | 2021 | 327 | 0.170 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2023 | 2200 | 0.170 |
Why?
|
Hyperkalemia | 1 | 2021 | 218 | 0.160 |
Why?
|
Ventricular Fibrillation | 3 | 2012 | 538 | 0.160 |
Why?
|
Body Fluids | 1 | 2020 | 319 | 0.160 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2019 | 1537 | 0.160 |
Why?
|
Adamantane | 1 | 2019 | 173 | 0.160 |
Why?
|
Advance Directives | 1 | 2020 | 246 | 0.160 |
Why?
|
Heart Transplantation | 2 | 2023 | 3112 | 0.160 |
Why?
|
Biomarkers, Pharmacological | 1 | 2019 | 162 | 0.160 |
Why?
|
Resuscitation Orders | 1 | 2020 | 269 | 0.150 |
Why?
|
Prognosis | 7 | 2024 | 29060 | 0.150 |
Why?
|
Troponin T | 1 | 2023 | 754 | 0.150 |
Why?
|
Cardiotonic Agents | 1 | 2021 | 535 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.150 |
Why?
|
Aerosols | 1 | 2020 | 625 | 0.150 |
Why?
|
Dipeptides | 1 | 2019 | 409 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 9955 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2023 | 2166 | 0.140 |
Why?
|
Job Satisfaction | 2 | 2011 | 534 | 0.140 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12356 | 0.140 |
Why?
|
Germany | 1 | 2019 | 862 | 0.140 |
Why?
|
Echocardiography | 2 | 2019 | 5099 | 0.140 |
Why?
|
Pulmonary Embolism | 2 | 2019 | 2375 | 0.140 |
Why?
|
Double-Blind Method | 3 | 2021 | 12025 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2018 | 243 | 0.130 |
Why?
|
Epinephrine | 1 | 2019 | 792 | 0.130 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 642 | 0.130 |
Why?
|
Chest Pain | 1 | 2023 | 1114 | 0.130 |
Why?
|
Disease Progression | 3 | 2023 | 13286 | 0.130 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2019 | 293 | 0.130 |
Why?
|
Respiratory Insufficiency | 2 | 2020 | 1199 | 0.130 |
Why?
|
Growth Differentiation Factor 15 | 3 | 2023 | 176 | 0.130 |
Why?
|
Renal Insufficiency | 1 | 2021 | 804 | 0.120 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 789 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2021 | 956 | 0.120 |
Why?
|
Hypotension | 1 | 2021 | 884 | 0.120 |
Why?
|
Carbon Dioxide | 1 | 2019 | 1150 | 0.120 |
Why?
|
Pulmonary Artery | 1 | 2023 | 1912 | 0.120 |
Why?
|
Electrocardiography | 3 | 2017 | 6442 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1239 | 0.110 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15535 | 0.110 |
Why?
|
Scoliosis | 1 | 2019 | 725 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2017 | 1851 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3954 | 0.100 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 896 | 0.100 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.100 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1364 | 0.100 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3841 | 0.100 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2162 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7914 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 1965 | 0.100 |
Why?
|
Comorbidity | 2 | 2023 | 10388 | 0.100 |
Why?
|
Platelet Aggregation | 1 | 2014 | 798 | 0.100 |
Why?
|
Foreign Medical Graduates | 1 | 2011 | 79 | 0.100 |
Why?
|
Survivors | 1 | 2021 | 2291 | 0.100 |
Why?
|
Niacin | 1 | 2011 | 116 | 0.090 |
Why?
|
Tissue Donors | 1 | 2020 | 2241 | 0.090 |
Why?
|
Pacemaker, Artificial | 1 | 2016 | 816 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2018 | 1541 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7147 | 0.090 |
Why?
|
Terminal Care | 1 | 2022 | 1694 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1793 | 0.090 |
Why?
|
Recovery of Function | 1 | 2019 | 2926 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2021 | 2873 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3255 | 0.080 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2760 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3537 | 0.080 |
Why?
|
Ticlopidine | 1 | 2014 | 899 | 0.080 |
Why?
|
Telephone | 1 | 2012 | 617 | 0.080 |
Why?
|
Survival Rate | 2 | 2020 | 12788 | 0.080 |
Why?
|
Radiography | 1 | 2019 | 7023 | 0.080 |
Why?
|
Incidence | 3 | 2023 | 20952 | 0.080 |
Why?
|
United States | 7 | 2022 | 69872 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2018 | 2278 | 0.080 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14723 | 0.080 |
Why?
|
Patient Selection | 1 | 2019 | 4216 | 0.070 |
Why?
|
Hypolipidemic Agents | 1 | 2011 | 604 | 0.070 |
Why?
|
Radioactive Fallout | 1 | 2005 | 8 | 0.070 |
Why?
|
Health Status | 1 | 2019 | 4034 | 0.070 |
Why?
|
Cohort Studies | 2 | 2019 | 40559 | 0.070 |
Why?
|
Fibrinolytic Agents | 1 | 2016 | 2158 | 0.070 |
Why?
|
Nuclear Warfare | 1 | 2005 | 31 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9145 | 0.070 |
Why?
|
Defibrillators | 1 | 2005 | 37 | 0.070 |
Why?
|
Heart Diseases | 1 | 2018 | 2789 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6755 | 0.060 |
Why?
|
Prospective Studies | 6 | 2023 | 53290 | 0.060 |
Why?
|
Adult | 9 | 2023 | 214052 | 0.060 |
Why?
|
Internal Medicine | 1 | 2011 | 1009 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3020 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12961 | 0.060 |
Why?
|
Emergency Service, Hospital | 2 | 2018 | 7658 | 0.060 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2023 | 85 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15078 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57776 | 0.060 |
Why?
|
Lecithins | 1 | 2022 | 16 | 0.060 |
Why?
|
Sterol O-Acyltransferase | 1 | 2022 | 27 | 0.050 |
Why?
|
Terrorism | 1 | 2005 | 211 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5135 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3318 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8479 | 0.050 |
Why?
|
Heart Valves | 1 | 2024 | 291 | 0.050 |
Why?
|
Survival Analysis | 1 | 2015 | 10252 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2023 | 77460 | 0.050 |
Why?
|
Catheters | 1 | 2023 | 425 | 0.040 |
Why?
|
Pneumocystis carinii | 1 | 2020 | 74 | 0.040 |
Why?
|
Disaster Planning | 1 | 2005 | 549 | 0.040 |
Why?
|
Coma | 1 | 2022 | 475 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 638 | 0.040 |
Why?
|
General Surgery | 1 | 2009 | 1636 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2016 | 39052 | 0.040 |
Why?
|
Angiography | 1 | 2022 | 1639 | 0.040 |
Why?
|
American Heart Association | 1 | 2021 | 1057 | 0.040 |
Why?
|
Students, Medical | 1 | 2009 | 1862 | 0.030 |
Why?
|
Shock | 1 | 2018 | 318 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6486 | 0.030 |
Why?
|
Animals | 3 | 2018 | 168768 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2560 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2919 | 0.030 |
Why?
|
Family | 1 | 2023 | 3147 | 0.030 |
Why?
|
Glycopeptides | 1 | 2012 | 226 | 0.020 |
Why?
|
Self-Help Groups | 1 | 2011 | 190 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2011 | 1681 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2012 | 552 | 0.020 |
Why?
|
Peroxidase | 1 | 2012 | 611 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2518 | 0.020 |
Why?
|
Social Perception | 1 | 2011 | 425 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1796 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7184 | 0.020 |
Why?
|
Personal Satisfaction | 1 | 2011 | 643 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1184 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9312 | 0.020 |
Why?
|
Body Mass Index | 1 | 2024 | 12721 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3116 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2011 | 1011 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2011 | 1813 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2011 | 2539 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2011 | 849 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2016 | 3817 | 0.010 |
Why?
|
Random Allocation | 1 | 2008 | 2428 | 0.010 |
Why?
|
Career Choice | 1 | 2009 | 744 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3749 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2355 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3508 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 12746 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6489 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3778 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 41005 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35134 | 0.010 |
Why?
|
Swine | 1 | 2008 | 5918 | 0.010 |
Why?
|
Communication | 1 | 2011 | 3750 | 0.010 |
Why?
|
Biomedical Research | 1 | 2012 | 3309 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10400 | 0.010 |
Why?
|
Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
Clinical Competence | 1 | 2009 | 4687 | 0.010 |
Why?
|
Research Design | 1 | 2009 | 5984 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2009 | 13991 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2009 | 25039 | 0.010 |
Why?
|